ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

House Committee Proposes $750 Mil. Increase For NIH, supports Bypass

May 4, 1990

In Brief: Senate Subcommittee Includes $2.7 Billion Increase for NIH in Budget Bill Markup

May 12, 2000

NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’

May 17, 1991

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

NSABP Agrees To Three-Month Search for Chairman Candidates, Review Of Plans

June 10, 1994

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001